[vc_row][vc_column][vc_column_text]Abstracts are invited on topics related to Oncology/allied and oncology sub-specialties.
Abstract submission deadline: January 15, 2019
Author’s notification: February 15, 2019
ABSTRACTS SUBMISSION GUIDELINES
Instructions for submitting an abstract
Abstracts should be submitted online or as a MS Word file to email@example.com
Scientific Committee will select the abstracts for either oral or poster presentation.
Preference must be indicated for oral or poster presentation, when submitting your abstract. However, the scientific committee’s decision will be final.
Authors are permitted to submit more than one abstract.
Abstract should be proofread for accuracy before submission.
Author and co-authors’ details
Full first and family name(s)
Affiliation details: department, institution / hospital, city, country. The name and address of the presenting author should be underlined together with e mail and telephone contact details
The title should be in capital lettering and no more than two lines in the top rectangle (not more than 20 words).
Your abstract should be of the informative type, max. 250 words, containing a statement of the study’s objectives, a brief statement of Material & Methods used a summary of the results and a conclusion.
- Title (2) Objectives (3) Material & Methods (4) Results (5) Conclusion.
Use only standard abbreviations. Use generic names of drugs. Authors can include only one figure, table or black/white illustration (maximum width 7 cm). Graphs can be inserted in the text as images (only JPG, PNG, and GIF files are accepted). The preferred font is Times New Roman.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”5px”][vc_column_text]
ABSTRACTS SUBMISSION FORM